Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer

27

Citations

37

References

2021

Year

Yat Hang To, Koen Degeling, Suzanne Kosmider, Rachel Wong, Margaret Lee, Catherine Dunn, Grace Gard, Azim Jalali, Vanessa Wong, Maarten J. IJzerman,

PharmacoEconomics

Surgical OncologyOncologyTumour DnaMedicineColorectal CancerPathologyCancer GenomicsPotential Cost-effective BiomarkerCancer TreatmentMolecular DiagnosticsRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1